The global mycoprotein market is projected to grow from USD 362.5 million in 2026 to USD 778.1 million by 2036, registering a CAGR of 7.9% during the forecast period. The market is expected to create an incremental opportunity of USD 415.6 million, supported by growing interest in alternative proteins, demand for meat-like textures, and advances in industrial fermentation. Food manufacturers are exploring mycoprotein for familiar meal formats, including mince-based products, burgers, sauces, and prepared foods, while ingredient suppliers are targeting opportunities to expand fungal protein use through business-to-business partnerships.
Minced mycoprotein is expected to remain the leading product form because it can be incorporated into established recipes and existing food manufacturing processes. Submerged liquid fermentation is also projected to maintain a dominant position, supported by its ability to provide consistent biomass production and controlled processing conditions. However, high fermentation costs, price differences compared with conventional meat, and the need to build consumer familiarity remain important challenges. Blended meat products, foodservice applications, and ingredient supply agreements present opportunities for manufacturers seeking to expand beyond conventional meat-free retail products.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14826
Global Segment Leaders
- Product Form – Minced Mycoprotein: Expected to account for 42.3% of the market by form type in 2026. Its versatility across burgers, sauces, fillings, and prepared meals supports demand from food manufacturers and consumers.
- Production Method – Submerged Liquid Fermentation (SLF): Projected to account for 86.4% of production-method revenue in 2026. Controlled fermentation conditions support consistent biomass production, texture, and protein characteristics at commercial scale.
- Other Product Forms: Sliced, powdered, and other mycoprotein formats provide additional opportunities across food manufacturing and emerging applications, including protein ingredients and prepared foods.
Country-Level Performance
Japan is projected to record the fastest growth among the countries profiled, with a CAGR of 10.2% through 2036. Public-private collaboration in food technology and interest in alternative protein development are expected to support commercialization opportunities.
The United States is forecast to expand at a CAGR of 9.9%, supported by investment in fungal protein production, ingredient innovation, and opportunities to supply food manufacturers. Companies are also exploring routes to broaden distribution beyond specialist retail channels.
The United Kingdom is expected to register a CAGR of 9.3%. Established familiarity with mycoprotein products and the presence of Quorn provide a foundation for further development across retail, foodservice, and blended-protein applications.
Germany is projected to grow at a CAGR of 8.8%, supported by consumer interest in meat reduction and opportunities to incorporate mycoprotein into blended meat products and prepared foods.
South Korea is forecast to record a CAGR of 8.1% through 2036. Food technology initiatives and growing interest in alternative protein development provide potential opportunities for suppliers, although the development of local supply and commercial applications will influence adoption.
Regional Context
The mycoprotein market spans North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa. Growth prospects differ according to consumer familiarity, food manufacturing capabilities, fermentation infrastructure, and the availability of commercial products.
Japan and South Korea represent developing opportunities in East Asia, where food technology investment and product adaptation could support market expansion. In North America, the United States is positioned for growth through investment in domestic fungal protein production, ingredient development, and partnerships with food manufacturers.
Western Europe benefits from established mycoprotein products, particularly in the United Kingdom, while Germany presents opportunities through meat alternatives and blended-protein applications. Across markets, manufacturers will need to improve production economics, deliver familiar taste and texture, and establish reliable supply arrangements to encourage repeat purchasing and wider commercial adoption.
The full report covers North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa, with country-level analysis of major markets, including Japan, the United States, the United Kingdom, Germany, and South Korea.
Access full Report in PDF Format@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14826
Competitive Landscape
The competitive landscape includes Marlow Foods Ltd. (Quorn), Meati Holdings, Nature’s Fynd, The Better Meat Co., ENOUGH (ABUNDA), MycoTechnology, Inc., and Smaqo. Companies compete through fermentation capabilities, product development, production economics, ingredient consistency, and access to retail and business-to-business customers.
Marlow Foods and Quorn represent established consumer-facing mycoprotein operations, while companies such as ENOUGH and The Better Meat Co. are developing opportunities in fungal biomass supply and ingredient partnerships. Nature’s Fynd and Meati Holdings also contribute to innovation in fungi-based protein products. MycoTechnology operates in fermentation-enabled ingredient innovation, while Smaqo is pursuing blended meat applications.
Recent developments highlight the market’s emphasis on commercial scale and broader applications. In November 2025, Meati Holdings announced a strategic revival following its acquisition of Meati assets, with a brand relaunch planned for 2026. In May 2026, Quorn returned its chilled mince product to Tesco and Sainsbury’s in the United Kingdom as part of its No Artificial Ingredients range. In July 2026, Quorn Pro and William White Meats introduced blended burgers, mince, and meatballs through wholesaler Brakes, expanding the use of mycoprotein in foodservice.
Looking ahead, companies that can reduce fermentation costs, improve product consistency, and establish reliable supply agreements with food manufacturers are positioned to pursue additional opportunities. Blended meat products and business-to-business ingredient applications could help extend mycoprotein adoption beyond established meat-free categories.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
